title: Editorial: Cancer Nanotheranostics: What Have We Learned So Far?
authors.affiliation: Harvard-MIT Division for Health Sciences and Technology, Institute for Medical Engineering and Science, Massachusetts Institute of TechnologyCambridge, MA, USA; School of Engineering and Materials Science, Queen Mary University of LondonLondon, UK.
authors.forename: João
authors.initials: J
authors.lastname: Conde
authors.affiliation: School of Food Science and Environmental Health, College of Sciences and Health, Dublin Institute of Technology Dublin, Ireland.
authors.forename: Furong
authors.initials: F
authors.lastname: Tian
authors.affiliation: Instituto de Ciencia de Materiales de Aragón, Consejo Superior de Investigaciones Científicas/Universidad de Zaragoza Zaragoza, Spain.
authors.forename: Jesus M
authors.initials: JM
authors.lastname: de la Fuente
authors.affiliation: Research Unit on Applied Molecular Biosciences (UCIBIO), Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa Lisboa, Portugal.
authors.forename: Pedro V
authors.initials: PV
authors.lastname: Baptista
keywords: cancer; nanomaterials; nanoparticles; nanotechnology; nanotheranostics; oncology